Clinical Trials Directory

Trials / Completed

CompletedNCT07480993

Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS

Evaluation of Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With Polycystic Ovary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
Female
Age
16 Years – 23 Years
Healthy volunteers
Accepted

Summary

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in adolescents and women of reproductive age and is frequently associated with insulin resistance and an increased risk of metabolic complications. The mechanisms underlying these metabolic abnormalities are not fully understood. Betatrophin (angiopoietin-like protein 8, ANGPTL8) is a liver- and adipose tissue-derived protein involved in lipid and glucose metabolism and has been suggested to be associated with insulin resistance and metabolic stress. This study aims to evaluate serum betatrophin levels in adolescents with PCOS compared with age-matched healthy controls. Adolescents with PCOS will also be categorized according to body mass index (BMI) as normal-weight or overweight to investigate the potential influence of body weight. Additionally, the relationships between betatrophin levels and anthropometric parameters, hormonal profiles, and markers of insulin resistance will be examined.

Conditions

Interventions

TypeNameDescription
OTHERSerum betatrophin levelsMeasurement of venous blood serum level of betatrophin by ELISA method. These measurements were performed in all groups (Overweight PCOS, Normal-weight PCOS, and Healthy Controls).

Timeline

Start date
2026-01-15
Primary completion
2026-03-02
Completion
2026-03-10
First posted
2026-03-18
Last updated
2026-03-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07480993. Inclusion in this directory is not an endorsement.